Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lens implant shows promise for clearer vision at all distances

NCT ID NCT06979557

Symptom relief Sponsor: Mann Eye Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how well the Odyssey intraocular lens works for people having refractive lens exchange to improve vision. Forty adults aged 40 and older received the lens in both eyes. Researchers measured vision at different distances and asked about symptoms and glasses use at least two months after surgery. The goal was to see if the lens provides good vision without major visual disturbances.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Odyssey intraocular lens (IOL) device
What this could lead to
If successful, this lens could improve near, intermediate, and distance vision after lens replacement surgery, reducing the need for glasses.
What could go wrong
This is a small, single-center study with only 40 participants and no comparison group. Results may not apply to everyone, and long-term effects are not assessed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Jul 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible test subjects will be aged 40 years and older who underwent bilateral implantation with the Odyssey IOL.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants will include 40 patients aged 40 years and older who have a measurable Potential Acuity Meter (PAM) of 20/20 electing to undergo bilateral refractive lensectomy surgery with IOL implantation. Exclusion Criteria: * Patients with significant ocular comorbidities (e.g., macular degeneration, glaucoma) or prior intraocular surgery will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Refractive lens exchange are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Refractive lens exchange

Contacts and locations

Locations

  • Mann Eye Institute

    Houston, Texas, 76134-2099, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.